263 related articles for article (PubMed ID: 17541047)
1. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs.
Libby AM; Brent DA; Morrato EH; Orton HD; Allen R; Valuck RJ
Am J Psychiatry; 2007 Jun; 164(6):884-91. PubMed ID: 17541047
[TBL] [Abstract][Full Text] [Related]
2. Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs.
Valuck RJ; Libby AM; Orton HD; Morrato EH; Allen R; Baldessarini RJ
Am J Psychiatry; 2007 Aug; 164(8):1198-205. PubMed ID: 17671282
[TBL] [Abstract][Full Text] [Related]
3. Persisting decline in depression treatment after FDA warnings.
Libby AM; Orton HD; Valuck RJ
Arch Gen Psychiatry; 2009 Jun; 66(6):633-9. PubMed ID: 19487628
[TBL] [Abstract][Full Text] [Related]
4. Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs.
Morrato EH; Libby AM; Orton HD; Degruy FV; Brent DA; Allen R; Valuck RJ
Am J Psychiatry; 2008 Jan; 165(1):42-50. PubMed ID: 17986680
[TBL] [Abstract][Full Text] [Related]
5. Impact of the 2004 Food and Drug Administration pediatric suicidality warning on antidepressant and psychotherapy treatment for new-onset depression.
Valluri S; Zito JM; Safer DJ; Zuckerman IH; Mullins CD; Korelitz JJ
Med Care; 2010 Nov; 48(11):947-54. PubMed ID: 20856141
[TBL] [Abstract][Full Text] [Related]
6. Pediatric prescribing practices and the FDA Black-box warning on antidepressants.
Cheung A; Sacks D; Dewa CS; Pong J; Levitt A
J Dev Behav Pediatr; 2008 Jun; 29(3):213-5. PubMed ID: 18550990
[TBL] [Abstract][Full Text] [Related]
7. National trends in prescribing antidepressants before and after an FDA advisory on suicidality risk in youths.
Chen SY; Toh S
Psychiatr Serv; 2011 Jul; 62(7):727-33. PubMed ID: 21724784
[TBL] [Abstract][Full Text] [Related]
8. Antidepressants use in pediatric populations.
Gören JL
Expert Opin Drug Saf; 2008 May; 7(3):223-5. PubMed ID: 18462180
[TBL] [Abstract][Full Text] [Related]
9. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents.
Gibbons RD; Brown CH; Hur K; Marcus SM; Bhaumik DK; Erkens JA; Herings RM; Mann JJ
Am J Psychiatry; 2007 Sep; 164(9):1356-63. PubMed ID: 17728420
[TBL] [Abstract][Full Text] [Related]
10. Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries.
Rihmer Z; Akiskal H
J Affect Disord; 2006 Aug; 94(1-3):3-13. PubMed ID: 16712945
[TBL] [Abstract][Full Text] [Related]
11. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
Nemeroff CB; Kalali A; Keller MB; Charney DS; Lenderts SE; Cascade EF; Stephenson H; Schatzberg AF
Arch Gen Psychiatry; 2007 Apr; 64(4):466-72. PubMed ID: 17404123
[TBL] [Abstract][Full Text] [Related]
12. The FDA pediatric advisories and changes in diagnosis and treatment of pediatric depression.
Pfeffer CR
Am J Psychiatry; 2007 Jun; 164(6):843-6. PubMed ID: 17541037
[No Abstract] [Full Text] [Related]
13. Pediatrician and family physician prescription of selective serotonin reuptake inhibitors.
Rushton JL; Clark SJ; Freed GL
Pediatrics; 2000 Jun; 105(6):E82. PubMed ID: 10835095
[TBL] [Abstract][Full Text] [Related]
14. Pediatric oncologists' practices of prescribing selective serotonin reuptake inhibitors (SSRIs) for children and adolescents with cancer: a multi-site study.
Phipps S; Buckholdt KE; Fernandez L; Wiener L; Kupst MJ; Madan-Swain A; Mullins L; Robert R; Sahler OJ; Vincent N; Noll RB
Pediatr Blood Cancer; 2012 Feb; 58(2):210-5. PubMed ID: 21284076
[TBL] [Abstract][Full Text] [Related]
15. The effect of regulatory advisories on maternal antidepressant prescribing, 1995-2007: an interrupted time series study of 228,876 pregnancies.
Bobo WV; Epstein RA; Hayes RM; Shelton RC; Hartert TV; Mitchel E; Horner J; Wu P
Arch Womens Ment Health; 2014 Feb; 17(1):17-26. PubMed ID: 24196827
[TBL] [Abstract][Full Text] [Related]
16. Antidepressants and suicide risk in the United States, 1985-1999.
Grunebaum MF; Ellis SP; Li S; Oquendo MA; Mann JJ
J Clin Psychiatry; 2004 Nov; 65(11):1456-62. PubMed ID: 15554756
[TBL] [Abstract][Full Text] [Related]
17. Changes in antidepressant medications prescribing trends in children and adolescents in Hawai'i following the FDA black box warning.
Hassanin H; Harbi A; Saif A; Davis J; Easa D; Harrigan R
Hawaii Med J; 2010 Jan; 69(1):17-9. PubMed ID: 20222492
[TBL] [Abstract][Full Text] [Related]
18. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
Hjalmarsson L; Corcos M; Jeammet P
Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
[TBL] [Abstract][Full Text] [Related]
19. The relationship between antidepressant medication use and rate of suicide.
Gibbons RD; Hur K; Bhaumik DK; Mann JJ
Arch Gen Psychiatry; 2005 Feb; 62(2):165-72. PubMed ID: 15699293
[TBL] [Abstract][Full Text] [Related]
20. What were the impacts of the Committee on Safety of Medicines warning and publication of the NICE guidelines on trends in child and adolescent antidepressant prescribing in primary care? A population based study.
Tiffin PA; Mediavilla JL; Close H; Kasim AS; Welsh P; Paton LW; Mason JM
BMJ Open; 2019 Aug; 9(8):e028201. PubMed ID: 31391190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
